Relaxin elicits renoprotective actions accompanied by increasing bile acid levels in streptozotocin-induced diabetic mice
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relaxin elicits renoprotective actions accompanied by increasing bile acid levels in streptozotocin-induced diabetic mice
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 162, Issue -, Pages 114578
Publisher
Elsevier BV
Online
2023-03-28
DOI
10.1016/j.biopha.2023.114578
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endothelium-dependent relaxation is impaired in Schlager hypertensive (BPH/2J) mice by region-specific mechanisms in conductance and resistance arteries
- (2023) Maria Jelinic et al. LIFE SCIENCES
- Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis
- (2022) Arnaud D. Kaze et al. Cardiovascular Diabetology
- Valorization of avocado seeds with antioxidant capacity using pressurized hot water extraction
- (2022) Eng Shi Ong et al. Scientific Reports
- Green Extraction of Orange Peel Waste Reduces TNFα-Induced Vascular Inflammation and Endothelial Dysfunction
- (2022) Chen Huei Leo et al. Antioxidants
- Diabetes Attenuates the Contribution of Endogenous Nitric Oxide but Not Nitroxyl to Endothelium Dependent Relaxation of Rat Carotid Arteries
- (2021) Jasmin Chendi Li et al. Frontiers in Pharmacology
- Relaxin has beneficial effects on liver lipidome and metabolic enzymes
- (2021) Alana Aragón‐Herrera et al. FASEB JOURNAL
- Pressurized Hot Water Extraction of Okra Seeds Reveals Antioxidant, Antidiabetic and Vasoprotective Activities
- (2021) Eng Shi Ong et al. Plants-Basel
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
- (2021) Hong Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects
- (2021) Jonatan Barrera-Chimal et al. Nature Reviews Nephrology
- The Novel Small-molecule Annexin-A1 Mimetic, Compound 17b, Elicits Vasoprotective Actions in Streptozotocin-induced Diabetic Mice
- (2020) Sarah A Marshall et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Basic Mechanisms of Diabetic Heart Disease
- (2020) Rebecca H. Ritchie et al. CIRCULATION RESEARCH
- Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes
- (2020) Guntram Schernthaner et al. Cardiovascular Diabetology
- Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways
- (2019) Hooi Hooi Ng et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of MajorAdverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
- (2019) Thomas A. Zelniker et al. CIRCULATION
- Recent developments in relaxin mimetics as therapeutics for cardiovascular diseases
- (2019) Chen Huei Leo et al. CURRENT OPINION IN PHARMACOLOGY
- Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue
- (2019) Alana Aragón-Herrera et al. PHARMACOLOGICAL RESEARCH
- Relaxin reduces endothelium‐derived vasoconstriction in hypertension: revealing new therapeutic insights
- (2019) Chen Huei Leo et al. BRITISH JOURNAL OF PHARMACOLOGY
- ANNEXIN‐A1 DEFICIENCY EXACERBATES PATHOLOGICAL REMODELLING OF THE MESENTERIC VASCULATURE IN INSULIN‐RESISTANCE BUT NOT INSULIN‐DEFICIENCY
- (2019) Maria Jelinic et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nitric Oxide Resistance, Induced in the Myocardium by Diabetes, Is Circumvented by the Nitric Oxide Redox Sibling, Nitroxyl
- (2019) Cheng Xue Qin et al. ANTIOXIDANTS & REDOX SIGNALING
- Diabetic kidney diseases revisited: A new perspective for a new era
- (2019) Haiyan Fu et al. Molecular Metabolism
- Bile acid receptors and the kidney
- (2018) Michal Herman-Edelstein et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- From pregnancy to cardiovascular disease: Lessons from relaxin-deficient animals to understand relaxin actions in the vascular system
- (2018) Maria Jelinic et al. MICROCIRCULATION
- Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
- (2018) Hooi Hooi Ng et al. Frontiers in Pharmacology
- The farnesoid X receptor: a potential target for expanding the therapeutic arsenal against kidney disease
- (2018) Christos Masaoutis et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Short-term (48 hours) intravenous serelaxin infusion has no effect on myogenic tone or vascular remodeling in rat mesenteric arteries
- (2017) Maria Jelinic et al. MICROCIRCULATION
- Serelaxin Treatment Reduces Oxidative Stress and Increases Aldehyde Dehydrogenase-2 to Attenuate Nitrate Tolerance
- (2017) Chen Huei Leo et al. Frontiers in Pharmacology
- Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes
- (2017) Hooi Hooi Ng et al. Scientific Reports
- Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats
- (2017) Dong Wang et al. Scientific Reports
- Relaxin deficiency attenuates pregnancy-induced adaptation of the mesenteric artery to angiotensin II in mice
- (2016) Sarah A. Marshall et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Anti-fibrotic actions of relaxin
- (2016) C S Samuel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin)
- (2016) C H Leo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta
- (2016) Hooi Hooi Ng et al. PHARMACOLOGICAL RESEARCH
- TGR5 activation suppressed S1P/S1P2 signaling and resisted high glucose-induced fibrosis in glomerular mesangial cells
- (2016) Zhiying Yang et al. PHARMACOLOGICAL RESEARCH
- Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries
- (2016) Nicola Kahlberg et al. PHARMACOLOGICAL RESEARCH
- Serelaxin: A Novel Therapeutic for Vascular Diseases
- (2016) Chen Huei Leo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes
- (2015) X. X. Wang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Relaxin-2 Does Not Ameliorate Nephropathy in an Experimental Model of Type-1 Diabetes
- (2015) Thomas Bernd Dschietzig et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Acute Intravenous Injection of Serelaxin (Recombinant Human Relaxin‐2) Causes Rapid and Sustained Bradykinin‐Mediated Vasorelaxation
- (2014) Chen Huei Leo et al. Journal of the American Heart Association
- Relaxin Treatment Reverses Insulin Resistance in Mice Fed a High-Fat Diet
- (2013) Jeffrey S. Bonner et al. DIABETES
- Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment
- (2013) Maria Jelinic et al. FASEB JOURNAL
- Relaxin Family Peptides and Their Receptors
- (2013) R. A. D. Bathgate et al. PHYSIOLOGICAL REVIEWS
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes
- (2013) Su Wong et al. PROTEIN AND PEPTIDE LETTERS
- Cellular and molecular mechanisms of renal fibrosis
- (2011) Youhua Liu Nature Reviews Nephrology
- Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes
- (2010) CH Leo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Relaxin Therapy Reverses Large Artery Remodeling and Improves Arterial Compliance in Senescent Spontaneously Hypertensive Rats
- (2010) Qi Xu et al. HYPERTENSION
- Unveiling the Vasodilatory Actions and Mechanisms of Relaxin
- (2010) Kirk P. Conrad HYPERTENSION
- Metabolic profiling in colorectal cancer reveals signature metabolic shifts during tumorigenesis
- (2010) E. S. Ong et al. MOLECULAR & CELLULAR PROTEOMICS
- Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
- (2008) J. M. Forbes et al. DIABETES
- Cytokine Secretion in Long-standing Diabetes Mellitus Type 1 and 2: Associations with Low-grade Systemic Inflammation
- (2008) Krystallenia I. Alexandraki et al. JOURNAL OF CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More